Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Neurocutaneous melanosis presenting with hydrocephalus & malignant transformation: case base update

Sharouf, F. ORCID:, Zaben, M. ORCID:, Lammie, A., Leach, P. and Bhatti, M I. 2018. Neurocutaneous melanosis presenting with hydrocephalus & malignant transformation: case base update. Child's Nervous System 34 (8) , pp. 1471-1477. 10.1007/s00381-018-3851-5

[thumbnail of Published Neurocutaneous 10.1007_s00381-018-3851-5.pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (810kB) | Preview


Introduction Neurocutaneous melanosis (NCM) is a sporadic condition characterized by congenital melanocytic nevi and melanocytic thickening of the leptomeninges. It is believed to result from congenital dysplasia of melanin producing-cells within the skin and leptomeninges. The management of cutaneous manifestations remains controversial, for neurological manifestations, outcome remains poor even with the use of radiotherapy and chemotherapy. Patients & Methods We describe the case of a 5-month old boy who presented with giant congenital melanocytic nevus and hydrocephalus. MR imaging and CSF immunohistochemistry confirmed leptomeningeal melanosis. We discuss the diagnosis, treatment and prognosis of this rare disorder in the light of recent published literature. Results Patient required placement of right sided ventriculoperitoneal shunt to control hydrocephalus. The patient tolerated the procedure well and was discharged home with normal neurological function. A presumptive diagnosis of NCM was made based on the MR characteristics, CSF cytology and clinical presentation. He received Trametinib, a MAPK/Erk kinase inhibitor for 7 months. At 30 months of age he developed left sided weakness and status epilepticus requiring paediatric intensive care unit admission and ventilator support. The patient eventually succumbed to malignant transformation of leptomeningeal disease Conclusion Cutaneous manifestations of NCM are usually congenital, and neurological manifestations develop early in life. Patients with large or multiple congenital nevi should therefore be investigated early to facilitate treatment. MR imaging is the investigation of choice which can further assist in performing biopsy. Symptomatic NCM is refractory to radiotherapy and chemotherapy and has a poor prognosis. A multidisciplinary approach is necessary in the management of NCM patients.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher: Springer Verlag (Germany)
ISSN: 0256-7040
Date of First Compliant Deposit: 22 May 2018
Date of Acceptance: 21 May 2018
Last Modified: 05 Jan 2024 08:33

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics